Infringement Analysis in Lausanne.

A patent infringement analysis Lausanne rights-holders can rely on has to fit a legal system unlike any of its neighbours, because Switzerland sits outside both the EU and the Unified Patent Court while hosting one of Europe’s densest deep-tech clusters. Lausanne, on the shore of Lake Geneva in the canton of Vaud, is the anchor of the Swiss “Health Valley” and home to EPFL — the École polytechnique fédérale de Lausanne — a spin-out engine that feeds medtech, life-sciences and robotics companies across the region. Every Swiss or European patent enforced here runs through a single specialised forum, the Swiss Federal Patent Court, and the deciding question is always the same: does the accused product fall within the claim? PerspireIP builds the claim charts and evidence-of-use that answer it, scoped to the court that will actually hear the case.

Where a patent infringement analysis Lausanne case is heard

A patent invented in a Lausanne laboratory is not litigated in Lausanne. Since 1 January 2012 Switzerland has channelled every civil patent dispute into one national forum: the Swiss Federal Patent Court (Bundespatentgericht / Tribunal fédéral des brevets), which holds exclusive nationwide jurisdiction over both the infringement and the validity of patents. There is no forum shopping in Switzerland and no cantonal patent court — a dispute arising in Vaud is heard by the same bench as one from Zurich or Geneva. The court’s seat is in St. Gallen, at the opposite end of the country from Lake Geneva, so a Health Valley matter travels east to a bench built specifically for technically dense patent cases.

What makes that bench distinctive is its composition. Panels combine legally qualified judges with technically trained judges — engineers and scientists with proven knowledge of patent law — so the court can read a patent specification and a teardown without translation by an expert. Proceedings run in one of the official languages, German, French or Italian, and the court will commonly allow English in briefs, exhibits and oral argument where the panel and all parties consent, although the judgment itself is always drafted in an official language. Appeals go to the Federal Supreme Court (Tribunal fédéral), which sits in Lausanne itself. A forum staffed by technical judges rewards a rigorous, element-by-element analysis over rhetoric.

• Swiss Federal Patent Court, St. Gallen — the sole first-instance court for Swiss patent infringement and validity, with mixed legal and technical panels
• Federal Supreme Court, Lausanne — the appeal court for Federal Patent Court decisions, seated in Vaud on Lake Geneva
• Language of the case — German, French or Italian, with English frequently permitted for briefs, evidence and hearings by consent
• One national forum — no cantonal patent courts and no forum shopping, so every Swiss patent action lands in the same specialist court

An EPC country outside the EU and the UPC

The single most important fact for anyone enforcing a patent here is jurisdictional: Switzerland is a member of the European Patent Convention (EPC), but it is not in the European Union and it is not part of the Unified Patent Court. A European patent can be granted by the European Patent Office and validated in Switzerland — an EP(CH) patent — but it takes effect as a national Swiss right and can never be a Unitary Patent. The UPC and its pan-European injunction simply do not reach Switzerland. Enforcement of a Swiss national patent or the Swiss part of a European patent happens in one place only: the Swiss Federal Patent Court.

That has a direct consequence for strategy. A rights-holder with a European portfolio may run a UPC action across the EU and a parallel Swiss action for the same invention — two forums, two bodies of case law, two evidentiary standards — and the claim charts have to be built for each. Confusing the two, or assuming a UPC judgment carries into Switzerland, is a costly error. A credible patent infringement analysis Lausanne counsel commission is scoped from the outset to the Swiss forum, its rules of claim construction and its remedies.

Swiss national patents add a second wrinkle. The Swiss Federal Institute of Intellectual Property (IPI/IGE) in Bern grants national patents without examining novelty or inventive step. A Swiss patent is therefore granted “without guarantee” and can be knocked out later for lack of novelty or inventiveness. Validity is not settled by the grant; it is fought out in the infringement action itself, where a nullity defence or counterclaim sits alongside the infringement read. Evidence of the prior art matters as much as evidence of use.

Lausanne, Vaud and the Health Valley patent docket

The character of the disputes coming out of Lausanne is written by its industry. Vaud and the Lake Geneva arc market themselves as Health Valley, and the gravitational centre is EPFL, whose laboratories spin out a steady stream of deep-tech companies. Around it sits a dense life-sciences and medtech ecosystem: Nestlé Research in Lausanne, the oncology-focused pharma company Debiopharm, the data-driven diagnostics firm Sophia Genetics, the neurorehabilitation and virtual-reality company MindMaze, and the Biopôle life-sciences campus in Épalinges that hosts hundreds of biotech and digital-health companies.

Robotics is the region’s other signature. EPFL is one of Europe’s leading robotics and drone research centres, and its heritage includes celebrated Lake Geneva spin-outs such as the mapping-drone maker senseFly and the collision-tolerant inspection-drone company Flyability. Lausanne is also the seat of the International Olympic Committee, reinforcing a local economy built on precision, imaging and sports-technology innovation. The result is a patent docket dominated by medical devices, biotech and mechatronics rather than the telecom-standards fights of other European hubs.

• Medtech & medical devices — EPFL spin-outs and neurotech such as MindMaze, where infringement turns on device teardowns and technical and regulatory files
• Life sciences & biotech — Debiopharm, Sophia Genetics, Nestlé Research and the Biopôle cluster, where claims read on formulations, analytical methods and processes
• Robotics & drones — the senseFly and Flyability heritage and EPFL robotics, where claims read on mechatronics plus embedded control software
• Digital health & imaging — algorithms and diagnostics proven from system behaviour, data pipelines and, where available, source code

Claim charts for medtech, life-sciences and robotics

Each of those sectors demands a different evidentiary craft, and this is where a patent infringement analysis Lausanne parties commission has to be tailored rather than templated. A medical-device claim is proven by a physical teardown: dimensioned photographs, materials analysis, and cross-referencing to the manufacturer’s own technical documentation and regulatory dossiers, so that each mechanical or electronic limitation is tied to a feature you can point to. Neurotech and imaging devices add a software layer, where firmware and user-facing behaviour must be captured and dated.

A life-sciences or biotech claim rarely yields to a photograph. Infringement of a formulation, a compound, an analytical method or a manufacturing process is shown from laboratory analysis, published product information, marketing authorisation data, scientific literature and, where a process is claimed, from indirect evidence that the accused output could only have been made by practising the method. The chart has to bridge the gap between what is claimed and what can lawfully be observed of a competitor’s confidential process.

A robotics claim is a hybrid. The mechatronic limitations — actuators, sensor placement, drivetrain, airframe — are charted from teardown and measurement, while the control and navigation limitations live in embedded software and are proven from observed behaviour, logs, telemetry and reverse-engineered firmware. A drone or surgical-robot claim that mixes hardware and algorithm needs both disciplines in one coherent chart. In every case the deliverable is the same shape: an element-by-element mapping the technical judges of the Federal Patent Court can test.

Proving infringement to the Swiss Federal Patent Court

The Federal Patent Court’s technical judges expect a disciplined file, not assertion. Because a Swiss patent is granted without substantive examination, validity is genuinely live in most infringement actions, and the analysis has to anticipate a nullity defence — pairing the infringement read with a clear view of the prior art and of how the claim will be construed. Switzerland also offers a precautionary taking-of-evidence procedure that lets a party secure and describe evidence of an alleged infringement before or early in proceedings; turning that secured material into a persuasive case still requires a chart that ties every fact to a claim limitation.

• Element-by-element claim charts mapping every limitation of the asserted claim to an observed feature of the accused product or process
• Evidence-of-use from teardowns, dimensioned imaging, laboratory analysis, firmware extraction, telemetry and dated public technical literature
• Claim construction fixed from the claims, description and prosecution history, argued for the Swiss forum rather than borrowed from a UPC or foreign judgment
• A coordinated validity view — prior art and nullity exposure — because a Swiss grant carries no examination guarantee and invalidity is regularly raised in defence
• Non-infringement and design-around positions for an accused implementer clearing a path to the Swiss market

The deliverable is scoped to the track. A national Swiss action before the Federal Patent Court, a request for precautionary measures, or the technical annex behind a licensing negotiation each demand a slightly different package. What never changes is the core: a claim chart an independent expert and a technically trained judge can adopt, built on evidence rather than conclusions, and framed for a country that stands outside the UPC.

How PerspireIP builds a Lausanne infringement-analysis file

Every engagement follows the same path. We fix the correct claim construction from the claims, description and prosecution history, then map each element against the real accused product or process. For medtech we work from teardowns, imaging and technical and regulatory files; for life sciences from laboratory analysis, product and authorisation data and the scientific literature; for robotics from mechatronic teardown combined with firmware and behavioural evidence — charting infringement literally and, where appropriate, under the doctrine of equivalents.

• Claim construction and element-by-element charting against a Swiss national patent or the Swiss part of a validated European patent (EP(CH))
• Evidence-of-use assembly — teardowns, imaging, laboratory data, firmware and public sources — dated for the Federal Patent Court or a precautionary-evidence request
• A paired validity view identifying prior art and nullity exposure, since a Swiss grant is not examined for novelty or inventive step
• Infringement and non-infringement positions built for either side, scoped to a country outside the EU and the UPC
• Deliverables sized to the matter — a single claim chart, a multi-patent dispute, or ongoing portfolio support — and coordinated with your Swiss and international counsel

We work alongside your Swiss and international counsel as a specialist analysis partner, deliver to Federal Patent Court deadlines, and keep every engagement confidential. Whether you are an EPFL spin-out, a Health Valley medtech or biotech company, a robotics firm enforcing a portfolio, an accused implementer clearing a path to the Swiss market, or litigation counsel preparing a claim or a defence, we scale to fit. Send us the patent number and the accused product, and we will scope the work within one business day.

IP Landscape & Resources in Lausanne

Key intellectual-property authorities and venues relevant to Lausanne:

• Swiss Federal Institute of Intellectual Property (IPI / IGE) — the federal office in Bern that grants Swiss national patents, notably without examining novelty or inventive step, so that validity is contested later in court
• Swiss Federal Patent Court (Bundespatentgericht / Tribunal fédéral des brevets) — the specialist court in St. Gallen with exclusive nationwide jurisdiction over Swiss patent infringement and validity, decided by mixed legal and technically trained panels since 2012
• Swiss Federal Supreme Court (Tribunal fédéral) — the highest Swiss court, seated in Lausanne, which hears appeals from the Federal Patent Court
• European Patent Office (EPO) — grants European patents that can be validated as a Swiss national right (EP(CH)); Switzerland is an EPC member but is outside the EU and the Unitary Patent and UPC system

Request a Patent Infringement Analysis in Lausanne

Explore related PerspireIP services: Patent Infringement Analysis · Prior Art Litigation Search · Patent Invalidation.

Frequently Asked Questions